LightPath Technologies Reports Fiscal 2026 Third Quarter Financial Results

By PR Newswire | May 07, 2026, 4:05 PM

ORLANDO, Fla., May 7, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2026.

Financial Summary:





Three Months Ended March 31,



$ in millions



2026





2025





% Change



Revenue



$

19.1





$

9.2







109

%

Gross Profit



$

7.0





$

2.7







161

%

Operating Expenses*



$

11.2





$

6.1







83

%

Net Loss



$

(4.1)





$

(3.6)







15

%

Adjusted EBITDA** (non-GAAP)



$

1.1





$

(1.6)







170

%

*Inclusive of $3.4 million and $0.1 million, respectively, for change in fair value of acquisition earnout liabilities.

**Reconciliation of this non-GAAP financial measure is provided below.

Third Quarter Fiscal 2026 & Subsequent Highlights: 

  • Ended the third quarter of fiscal 2026 with a record order backlog of approximately $110.6 million, an increase of 196% from $37.4 million as of June 30, 2025, reflecting growing customer demand for infrared cameras, assemblies, and BlackDiamond™ based optical solutions.
  • Acquired the assets of Amorphous Materials, Inc. ("AM") in January 2026, an industrial manufacturer with complementary Chalcogenide glass melting technologies for large diameter optics, adding a second U.S. manufacturing location for BlackDiamond™ glass.
  • Hosted an Investor Day in February 2026, during which management outlined the Company's updated three pillar growth strategy targeting in excess of $300 million in annual revenue within five years, anchored by assemblies, infrared camera systems, and large defense programs.
  • Appointed Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management in April 2026, adding more than 40 combined years of defense, aerospace, and Electro-Optical/Infrared business development experience to accelerate conversion of pipeline into contracted revenue.

Management Commentary 

Sam Rubin, President and Chief Executive Officer of LightPath, said: "The third quarter of fiscal 2026 demonstrated continued execution against our vertically integrated strategy, with revenue growing 109% year over year to $19.1 million and gross profit expanding 161% year over year to $7.0 million. We delivered our third consecutive quarter of positive adjusted EBITDA and ended the quarter with a record order backlog of $110.6 million, up 196% from the start of the fiscal year. The scale and quality of our backlog is the clearest indication yet that LightPath has established itself as a mission critical supplier for some of the most important optical and infrared imaging programs in the U.S. and allied defense industrial base.

"The strategic thesis we have been executing against for the past several years continues to be reinforced by customer behavior and U.S. government policy. The Fiscal Year 2026 National Defense Authorization Act directs the U.S. Department of War to eliminate reliance on optical glass and optical systems sourced from certain foreign nations by January 1, 2030. Our broad offering of BlackDiamond™ chalcogenide glasses, including those licensed exclusively from the U.S. Naval Research Laboratory, along with our infrared cameras, assemblies, and thermal imaging systems, are already designed, manufactured, and delivered in alignment with those requirements. With the addition of AM, we now operate two U.S. based BlackDiamond™ glass production sites and have expanded our infrared glass portfolio to roughly 20 proprietary compositions, which is among the broadest selection of infrared materials available anywhere.

"Our February Investor Day laid out where we go from here. We are organizing the business around three pillars of growth: optical assemblies, infrared camera systems, and large defense programs of record. Each pillar has an addressable market measured in hundreds of millions to billions of dollars, and each is enabled by the same underlying BlackDiamond™, molding, coating, and camera technologies. Programs such as NGSRI, SPEIR, Apache, border surveillance, and counter UAS are no longer theoretical; they are in production or nearing it, and they increasingly carry BlackDiamond™ content. We are on track to complete the redesign of G5's cooled infrared camera family onto BlackDiamond™ by the end of summer 2026, and beleive that this will position LightPath to meet long range camera demand at scale while competitors continue to work through the Germanium supply constraint.

"With a strong balance sheet, two operating glass manufacturing facilities, an expanded camera portfolio, and a deeper senior commercial leadership team following the appointments of Doug Schoen and Ryan Workman, we believe LightPath is well positioned to continue converting our record backlog into revenue, expand margins as volume scales, and pursue further accretive M&A that accelerates our transition into a platform provider of mission critical optical and imaging solutions," concluded Rubin.

Third Quarter Fiscal 2026 Financial Results

Revenue for the third quarter of fiscal 2026 increased 109% to $19.1 million, as compared to $9.2 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company's product groups in the third quarter of fiscal 2026 and the same quarter of the prior fiscal year as follows:

Product Group Revenue ($ in millions)***



Third Quarter of

Fiscal 2026





Third Quarter of

Fiscal 2025





% Change



Infrared ("IR") Components



$

6.1





$

3.6







69 %



Visible Components



$

4.0





$

2.8







40 %



Assemblies & Modules



$

8.4





$

1.9







355 %



Engineering Services



$

0.6





$

0.8







(29) %



*** Numbers may not foot due to rounding

Gross profit increased 161.1% to $7.0 million, or 36% of total revenues, in the third quarter of fiscal 2026, as compared to $2.7 million, or 29% of total revenues, in the same year-ago quarter. The increase in gross margin as a percentage of revenue was primarily driven by the increase in revenue from assemblies and modules, which generally carry higher margins, as well as an improved infrared component mix and manufacturing yields.

Operating expenses for the third quarter of fiscal 2026 include a fair value adjustment of $3.4 million related to the G5 earnout liability, which will continue to be adjusted through operating expenses until it is fully paid out. Excluding this amount, operating expenses increased $1.8 million, or 30%, to $7.8 million for the third quarter of fiscal 2026, as compared to $6.0 million in the same year-ago quarter. The increase was primarily driven by integration of G5 Infrared and AM, increased sales and marketing spend, higher information technology spend to meet customer security requirements, and increased SG&A personnel costs.

Net loss in the third quarter of fiscal 2026 totaled $4.1 million, or $0.07 per basic and diluted share, as compared to $3.6 million, or $0.44 per basic and diluted share, in the same year-ago quarter. The year-over-year change in net loss was primarily attributable to the change in fair value of acquisition liabilities for the earnout related to the acquisition of G5 Infrared.

Adjusted EBITDA** for the third quarter of fiscal 2026 was $1.1 million, as compared to an adjusted EBITDA loss of $1.6 million for the same year-ago quarter. The increase was primarily attributable to the increase in gross profit, driven by higher sales, partially offset by increased SG&A and new product development costs.

Cash and cash equivalents as of March 31, 2026 totaled $55.2 million, as compared to $4.9 million as of June 30, 2025. Total backlog as of March 31, 2026 was approximately $110.6 million, an increase of 196% compared to $37.4 million as of June 30, 2025.

Third Quarter Fiscal 2026 Earnings Call

Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, May 7, 2026, to discuss the Company's third quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Q3 FY2026 Earnings Conference Call

Date: Thursday, May 7, 2026

Time: 5:00 p.m. Eastern time

U.S. Dial-in: 1-833-316-1983

International Dial-in: 1-785-838-9310

Conference ID: LIGHT

Webcast: LPTH Q3 FY2026 Earnings Conference Call

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Thursday, May 21, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 11161627. A webcast replay will also be available using the webcast link above.

About LightPath Technologies

LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials – sold under exclusive license from the U.S. Naval Research Laboratory – to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.

**Use of Non-GAAP Financial Measures

To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to the warrants; (4) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; (5) acquisition costs, including legal fees and due diligence; and (6) the effect of foreign exchange gains or losses.

A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.

LIGHTPATH TECHNOLOGIES, INC.

Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure







(unaudited)













Three Months Ended





Nine Months Ended







March 31,





March 31,







2026





2025





2026





2025



Net loss



$

(4,106,287)





$

(3,582,460)





$

(16,404,698)





$

(7,817,202)



Depreciation and amortization





1,263,005







1,463,150







3,717,691







3,356,752



Income tax provision





91,390







100,031







203,216







160,192



Interest (income) expense





(271,641)







486,833







282,235







805,246



EBITDA



$

(3,023,533)





$

(1,532,446)





$

(12,201,556)





$

(3,495,012)



Stock-based compensation





562,966







239,134







1,261,577







745,155



Loss on extinguishment of debt











418,502







506,280







418,502



Change in fair value of warrant liability











(870,554)













(870,554)



Change in fair value of acquisition earnout liabilities





3,393,000







130,445







12,234,529







130,445



Acquisition costs





145,539













220,175









Foreign exchange loss (gain)





59,195







(7,627)







115,264







(11,701)



Adjusted EBITDA



$

1,137,167





$

(1,622,546)





$

2,136,269





$

(3,083,165)



% of revenue





6

%





-18

%





4

%





-12

%

Forward-Looking Statements

This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding expectations, beliefs, hopes, intentions or strategies regarding, among other things, the Company's ability to execute on its growth strategy to deliver revenue growth and value to its shareholders; the Company's belief that it has established itself as a mission critical supplier for programs in the U.S. and allied defense industrial base; the Company's expectations regarding customer behavior and U.S. government policy; the Company's expectations regarding its timing of the redesign of G5's infrared products; the Company's ability to grow its backlog, expand margins as volume scales and pursue acquisitions, as well as other statements that are other than historical fact. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the likelihood that the impact of varying demand for the Company products; the U.S. government's initiatives to move away from using optical systems from certain foreign nations; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; the Company's reliance on a few key customers; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to internal customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas-Israel war; the effects of steps that the Company could take to reduce operating costs; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets

(unaudited)







March 31,





June 30,







2026





2025



Assets

















Current assets:

















Cash and cash equivalents



$

55,235,181





$

4,877,036



Trade accounts receivable, net of allowance of $49,017 and $24,495





10,797,645







9,455,310



Inventories, net





13,344,705







12,858,838



Prepaid expenses and deposits





3,440,598







1,142,661



Other current assets





185,503







40,150



Total current assets





83,003,632







28,373,995





















Property and equipment, net





15,828,239







15,864,061



Operating lease right-of-use assets





8,406,283







7,429,378



Intangible assets, net





17,589,628







15,987,923



Goodwill





19,315,177







13,753,921



Deferred tax assets, net





22,233







22,571



Other assets





99,987







73,917



Total assets



$

144,265,179





$

81,505,766



Liabilities and Stockholders' Equity

















Current liabilities:

















Accounts payable



$

6,030,975





$

7,421,430



Accrued liabilities





10,813,017







5,686,396



Accrued payroll and benefits





3,125,747







2,359,152



Operating lease liabilities, current





1,177,423







1,254,062



Loans payable, current portion





113,085







172,567



Finance lease obligation, current portion





271,015







206,518



Total current liabilities





21,531,262







17,100,125



Deferred tax liabilities, net





88,099







152,760



Accrued liabilities, noncurrent











823,000



Finance lease obligation, less current portion





460,316







421,363



Operating lease liabilities, noncurrent





9,197,980







8,326,250



Loans payable, less current portion





103,661







4,804,990



Total liabilities





31,381,318







31,628,488





















Commitments and Contingencies



































Series G Convertible Preferred Stock; $0.01 par value; 44,000 shares authorized; 17,346

and 24,956 shares issued and outstanding



$

23,794,184





$

34,232,510





















Stockholders' equity:

















Preferred stock: Series D, $0.01 par value, voting; 500,000 shares authorized; none issued

and outstanding













Common stock: Class A, $0.01 par value, voting; 94,500,000 shares authorized; 61,207,012

and 42,949,307 shares issued and outstanding





612,070







429,493



Additional paid-in capital





334,313,395







244,953,346



Accumulated other comprehensive income





1,285,667







978,686



Accumulated deficit





(247,121,455)







(230,716,757)



Total stockholders' equity





89,089,677







15,644,768



Total liabilities, convertible preferred stock and stockholders' equity



$

144,265,179





$

81,505,766



LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(unaudited)







Three Months Ended





Nine Months Ended







March 31,





March 31,







2026





2025





2026





2025



Revenue, net



$

19,149,814





$

9,167,627





$

50,559,747





$

24,992,837



Cost of sales





12,193,531







6,503,526







33,100,562







17,553,476



Gross profit





6,956,283







2,664,101







17,459,185







7,439,361



Operating expenses:

































Selling, general and administrative





6,296,286







4,448,359







16,539,617







11,075,005



New product development





1,041,794







757,938







2,658,051







1,998,775



Amortization of intangible assets





477,245







779,025







1,378,295







1,469,512



Change in fair value of acquisition earnout liabilities





3,393,000







130,445







12,234,529







130,445



Loss on disposal of property and equipment











2,068







4,016







80,505



Total operating expenses





11,208,325







6,117,835







32,814,508







14,754,242



Operating loss





(4,252,042)







(3,453,734)







(15,355,323)







(7,314,881)



Other income (expense):

































Interest income (expense), net





271,641







(486,833)







(282,235)







(805,246)



Loss on extinguishment of debt











(418,502)







(506,280)







(418,502)



Change in fair value of warrant liability











870,554













870,554



Other expense (income), net





(34,496)







6,086







(57,644)







11,065



Total other income (expense)





237,145







(28,695)







(846,159)







(342,129)



Loss before income taxes





(4,014,897)







(3,482,429)







(16,201,482)







(7,657,010)



Income tax provision





91,390







100,031







203,216







160,192



Net loss



$

(4,106,287)





$

(3,582,460)





$

(16,404,698)





$

(7,817,202)



Foreign currency translation adjustment





1,739







120,572







306,981







(58,869)



Comprehensive loss



$

(4,104,548)





$

(3,461,888)





$

(16,097,717)





$

(7,876,071)



Loss per common share (basic)



$

(0.07)





$

(0.09)





$

(0.33)





$

(0.19)



Number of shares used in per share calculation (basic)





58,628,741







41,363,643







49,572,872







40,209,657



Loss per common share (diluted)



$

(0.07)





$

(0.09)





$

(0.33)





$

(0.19)



Number of shares used in per share calculation (diluted)





58,628,741







41,363,643







49,572,872







40,209,657



LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Changes in Stockholders' Equity

(unaudited)









Temporary Equity





























Accumulated























Series G Convertible





Class A





Additional





Other













Total







Preferred Stock





Common Stock





Paid-in





Comprehensive





Accumulated





Stockholders'







Shares





Amount





Shares





Amount





Capital





Income





Deficit





Equity



Balances at June 30, 2025





24,956





$

34,232,510







42,949,307





$

429,493





$

244,953,346





$

978,686





$

(230,716,757)





$

15,644,768



Issuance of common stock for:

































































Exercise of stock options, RSUs &RSAs, net

















8,583







86







(86)





















Issuance of common stock under private equity placement

















1,600,000







16,000







7,878,045



















7,894,045



Issuance of common stock for acquisition of Visimid

















112,323







1,123







348,877



















350,000



Stock-based compensation on stock options, RSUs &RSAs





























349,624



















349,624



Foreign currency translation adjustment



































92,383













92,383



Net loss









































(2,893,002)







(2,893,002)



Balances at September 30, 2025





24,956





$

34,232,510







44,670,213





$

446,702





$

253,529,806





$

1,071,069





$

(233,609,759)





$

21,437,818



Issuance of common stock for:

































































Exercise of stock options, RSUs &RSAs, net

















120,234







1,203







(1,203)





















Exercise of warrants

















739,730







7,397







(7,397)





















Issuance of common stock under public equity placement

















8,912,500







89,125







65,251,709



















65,340,834



Stock-based compensation on stock options, RSUs & RSAs





























348,986



















348,986



Foreign currency translation adjustment



































212,859













212,859



Net loss









































(9,405,409)







(9,405,409)



Balances at December 31, 2025





24,956





$

34,232,510







54,442,677





$

544,427





$

319,121,901





$

1,283,928





$

(243,015,168)





$

77,935,088



Issuance of common stock for:

































































Employee Stock Purchase Plan

















2,302







23







24,839



















24,862



Exercise of stock options, RSUs & RSAs, net

















112,723







1,127







11,376



















12,503



Exercise of warrants

















2,728,968







27,290







(27,290)





















Fees for issuance of common stock under public equity placement





























(98,293)



















(98,293)



Issuance of common stock for acquisition of Amorphous

















83,518







835







1,026,245



















1,027,080



Issuance of common stock for acquisition of G5

















297,445







2,974







3,146,968



















3,149,942



Conversion of Series G Preferred to Common





(7,610)







(10,438,326)







3,539,379







35,394







10,402,932



















10,438,326



Stock-based compensation on stock options, RSUs & RSAs





























704,717



















704,717



Foreign currency translation adjustment



































1,739













1,739



Net loss









































(4,106,287)







(4,106,287)



Balances at March 31, 2026





17,346





$

23,794,184







61,207,012





$

612,070





$

334,313,395





$

1,285,667





$

(247,121,455)





$

89,089,677





































































Balances at June 30, 2024









$







39,254,643





$

392,546





$

245,140,758





$

509,936





$

(215,843,575)





$

30,199,665



Issuance of common stock for:

































































Employee Stock Purchase Plan

















8,232







82







10,290



















10,372



Exercise of Stock Options, RSUs & RSAs, net

















70,309







703







(703)





















Issuance of common stock for acquisition of Visimid

















279,553







2,796







318,562



















321,358



Stock-based compensation on stock options, RSUs & RSAs





























264,475



















264,475



Foreign currency translation adjustment



































271,594













271,594



Net loss









































(1,622,745)







(1,622,745)



Balances at September 30, 2024









$







39,612,737





$

396,127





$

245,733,382





$

781,530





$

(217,466,320)





$

29,444,719



Issuance of common stock for:

































































Exercise of Stock Options, RSUs & RSAs, net

















229,097







2,291







(2,291)





















Shares issued as compensation

















49,000







490







89,180



















89,670



Stock-based compensation on stock options, RSUs & RSAs





























231,581



















231,581



Foreign currency translation adjustment



































(451,035)













(451,035)



Net loss









































(2,611,997)







(2,611,997)



Balances at December 31, 2024









$







39,890,834





$

398,908





$

246,051,852





$

330,495





$

(220,078,317)





$

26,702,938



Issuance of preferred stock under private equity placement, net of fees





24,956







19,648,488







































Issuance of common stock for:

































































Employee Stock Purchase Plan

















1,137







11







4,002



















4,013



Exercise of Stock Options, RSUs & RSAs, net

















238,641







2,387







788



















3,175



Issuance of common stock for acquisition of Visimid

















102,700







1,027







391,561



















392,588



Issuance of common stock for acquisition of G5

















1,972,501







19,725







4,852,343



















4,872,068



Issuance of common stock under private equity placement, net of fees

















687,750







6,878







1,584,014



















1,590,892



Issuance of warrants under private placement, net of fees





























177,445



















177,445



Preferred cumulative dividends plus accretion











14,751,134



















(14,751,134)



















(14,751,134)



Stock-based compensation on stock options, RSUs & RSAs





























194,303



















194,303



Foreign currency translation adjustment



































120,572













120,572



Net loss









































(3,582,460)







(3,582,460)



Balances at March 31, 2025





24,956





$

34,399,622







42,893,563





$

428,936





$

238,505,174





$

451,067





$

(223,660,777)





$

15,724,400



LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)







Nine Months Ended







March 31,







2026





2025



Cash flows from operating activities:

















Net loss



$

(16,404,698)





$

(7,817,202)



Adjustments to reconcile net loss to net cash used in operating activities:

















Depreciation and amortization





3,717,691







3,356,752



Interest from amortization of loan issuance costs





90,124







161,905



Amortization of fair value of loan





90,321









Loss on extinguishment of debt





506,280







418,502



Change in fair value of warrant liability











(870,554)



Change in fair value of acquisition earnout liabilities





12,234,529







130,445



Earnout payment for acquisition of G5, net of financing portion





(3,813,587)









Loss on disposal of property and equipment





4,016







80,505



Stock-based compensation on stock options, RSUs & RSAs, net





1,261,577







745,155



Provision for credit losses





(26,034)







(3,014)



Change in operating lease assets and liabilities





(181,814)







(91,582)



Inventory write-offs to allowance





215,129







135,625



Deferred taxes





(64,323)







(2,368)



Changes in operating assets and liabilities, net of acquisitions:

















Trade accounts receivable





(1,200,965)







(822,043)



Other current assets





(145,353)







73,362



Inventories





(247,597)







(1,206,340)



Prepaid expenses and deposits





(2,182,257)







(360,439)



Accounts payable and accrued liabilities





1,030,382







389,844



Net cash used in operating activities





(5,116,579)







(5,681,447)





















Cash flows from investing activities:

















Purchase of property and equipment





(1,844,395)







(580,726)



Proceeds from sale of equipment











10,648



Acquisition of Amorphous





(7,000,111)









Acquisition of G5











(20,250,011)



Net cash used in investing activities





(8,844,506)







(20,820,089)





















Cash flows from financing activities:

















Proceeds from exercise of stock options





12,503







3,175



Proceeds from sale of common stock from Employee Stock Purchase Plan





24,862







14,385



Proceeds from issuance of common stock under public equity placement, net of fees





65,242,541









Proceeds from issuance of common stock under private equity placement, net of fees





7,894,045







437,725



Proceeds from issuance of preferred stock under private equity placement, net of fees











18,842,138



Proceeds from issuance of warrants under private equity placement, net of fees











4,620,561



Earnout payment for acquisition of G5, net of operating portion





(3,536,471)









Deferred payment for acquisition of Visimid











(125,000)



Borrowings on loans payable











6,659,596



Loan issuance costs











(597,465)



Payments on loans payable





(5,442,930)







(149,118)



Repayment of finance lease obligations





(168,089)







(133,711)



Net cash provided by financing activities





64,026,461







29,572,286



Effect of exchange rate on cash and cash equivalents





292,769







(72,133)



Change in cash and cash equivalents





50,358,145







2,998,617



Cash and cash equivalents, beginning of period





4,877,036







3,480,268



Cash and cash equivalents, end of period



$

55,235,181





$

6,478,885





















Supplemental disclosure of cash flow information:

















Interest paid in cash



$

390,457





$

66,136



Income taxes paid



$

194,527





$

118,016



Supplemental disclosure of non-cash investing & financing activities:

















Purchase of equipment through finance lease arrangements



$

275,471





$

93,048



Operating right-of-use assets acquired in exchange for operating lease liabilities



$

1,956,911





$



Issuance of common stock for acquisition of Visimid



$

350,000





$

713,946



Issuance of common stock for acquisition of G5, including earnouts



$

3,149,942





$

4,872,068



Issuance of common stock for acquisition of AML, including earnouts



$

1,027,080





$



Accrual of earnout consideration for acquisition of G5



$





$

3,536,471



Accrual of earnout consideration for acquisition of AML



$

1,780,000





$



Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note



$





$

3,057,110



Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-fiscal-2026-third-quarter-financial-results-302764869.html

SOURCE LightPath Technologies

Latest News

May-08
May-07
Apr-30
Apr-08
Apr-06
Feb-28
Feb-18
Feb-12
Feb-11
Feb-11
Feb-11
Feb-11
Feb-09
Feb-04
Jan-29